Comparing the prices of dabrafenib and trametinib in China, which one is more affordable?

Trametinib and dabrafenib are both targeted therapy drugs used to treat BRAF mutant malignant melanoma, thyroid cancer, non-small cell lung cancer and other cancers. Although these two drugs are often used together, their prices differ greatly, and patients need to consider the economics of the drug when choosing.

The original drug of trametinib has been launched in the Chinese market. Common specifications include2mg 30 tablets and 0.5mg 30 tablets, priced at approximately RMB 10,000 per box. Due to its remarkable efficacy and inclusion in medical insurance, many patients who meet the indications can be reimbursed for part of the cost through medical insurance policies. However, the proportion and conditions of medical insurance reimbursement vary from region to region, and patients need to consult the local medical insurance department for specific reimbursement situations.

In comparison, the original drug of dabrafenib is priced relatively high in the Chinese market.A box of 50mg*120 pills can be sold for more than 10,000 yuan per box. Although dabrafenib has also been included in medical insurance and has certain reimbursement coverage, the treatment cost of dabrafenib is more expensive than trametinib. In addition, dabrafenib and trametinib are often used in combination, so patients bear the cost of both, further increasing the overall cost of treatment.

In overseas markets, especially in regions such as Turkey, the prices of the original drugs of dabrafenib and trametinib are cheaper than in China. The price of dabrafenib and trametinib in the Turkish market is about 7,000 yuan per box. However, patients need to pay attention to factors such as exchange rate fluctuations and import taxes when purchasing, which may affect the price. For patients with a more limited budget, it may be an affordable choice to choose some generic drugs from countries such as India, Bangladesh or Laos. The price of these generic drugs is usually much lower, which may range from 2,000 to 3,000 yuan, but the efficacy and safety of the generic drugs should be consistent with the original drugs.

Reference materials:https://go.drugbank.com/drugs/DB08911